Research & Development



  “我來治,我來治,你讓我先看看骨頭的模樣!”   他們在城門口就看了那個年輕的軍司馬。超碰视频夫妻在线播放   “跟我睡吧,我怕你不小心跑甦稚屋子里,以後我會多出來一個宦官朋友。”色和尚在线视频久   “怎麼,沒有留你母親在這里過夜?”   文皇帝給他升官兩三次,先帝又給他升過官,那麼,這家伙絕對是中常侍,至于劉徹沒有給他升官的原因,很可能就是因為這家伙的官職已經升到頭了,沒法升了。噜噜吧   阿嬌打了一個冷顫道︰“人彘蠶室的首領宦官,妾身听著都害怕,當了八年的皇後,就見過他一次。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo